Extendicare (TSE:EXE – Get Free Report) had its target price raised by Cormark from C$25.00 to C$30.00 in a research report issued on Wednesday,BayStreet.CA reports. Cormark’s price objective suggests a potential upside of 44.72% from the company’s current price.
A number of other research firms have also commented on EXE. BMO Capital Markets raised their price target on shares of Extendicare from C$15.00 to C$21.00 in a research report on Monday, November 17th. Cibc World Mkts upgraded shares of Extendicare to a “strong-buy” rating in a research report on Monday, September 22nd. CIBC raised their price objective on Extendicare from C$18.00 to C$22.00 in a research note on Thursday, November 13th. TD Securities upped their target price on Extendicare from C$15.00 to C$19.00 in a research report on Thursday, November 13th. Finally, National Bankshares upped their price objective on shares of Extendicare from C$21.50 to C$24.50 and gave the stock an “outperform” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Extendicare currently has a consensus rating of “Buy” and an average price target of C$23.30.
View Our Latest Stock Analysis on EXE
Extendicare Stock Performance
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- NASA Calls, Plug Answers: A Turning Point for Hydrogen?
- How to Profit From Growth Investing
- Will 2026 Mark a Turnaround for Costco?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- The AI Boom Is Powering an Unexpected Stock SurgeāAnd These 3 Companies Are Winning Big
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
